# XPOVIO

NDC: 72237-101
Generic name: selinexor
Labeler / Manufacturer: Karyopharm Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190710

FDA application: NDA212306

## Active ingredients

- SELINEXOR: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72237-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72237-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd2682-75a6-4863-90a8-a3197f6f78a8